Mass spectrometric study of in vivo production of advanced glycation end-products/peptides

Journal of Mass Spectrometry

Volumn 40, Issue 7, 2005, Pages 969-972

  Lapolla, A ^b   Fedele, D ^b   Reitano, R ^b   Bonfante, L ^b   Guizzo, M ^b   Seraglia, R ^a   Tubaro, M ^a   Traldi, P ^a  

^a CNR   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; ANALYTIC METHOD; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; LETTER; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEOMICS;

CHROMATOGRAPHY, LIQUID; DIABETES INSIPIDUS; DIABETES MELLITUS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; PEPTIDES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 23244460523     PISSN: 10765174     EISSN: None     Source Type: Journal    
DOI: 10.1002/jms.842     Document Type: Letter

References (18)

1. 6-(2,3-dihydroxy-5,6-dioxohexyl)-L- lysinate by LC-(ESI)MS peptide mapping: evidence for its key role in AGE formation. Bioconj. Chem. 2003; 14: 619.
2. Sing R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 2001; 44: 129.
3. Papanastasiou P, Grass L, Rodela H, Patrikarea A, Oreopoulos D, Diamandis EP. Immunological quantification of advanced glycation end products in the serum of patients in hemodialysis or CAPD. Kidney Int. 1994; 46: 216.
4. Korbert SM, Makita Z, Firanek CA, Vlassara H. Advanced glycosylation end products in continuous ambulatory peritoneal dialysis patients. J. Kidney Dis. 1993; 22: 588.
5. Makita Z, Bucala R, Rayfield EJ, Friedeman EA, Kaufman AM, Korbet SM, Barth RH, Winston JA, Fuh H, Manogue KR. Reactive glycosylation end products in diabetic uremia and treatment of renal failure. Lancet 1994; 343: 1519.
6. Mitsuhashi T, Nakayama H, Itoh T, Kuwajima S, Aoki S, Atsumi T, Koike T. Immunological quantification of advanced glycation end products in the renal cortex from streptozoticin-induced diabetic rats. Diabetes 1993; 42: 826.
7. Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, Vlassara H. Modification of low density lipoproteinby advanced glycation endproducts contributes to the dyslipidemia of diabetes and renal insufficiency. Proc. Natl. Acad. Sci. USA 1994; 91: 9441.
8. Gugliucci A, Bendayan M. Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia 1996; 39: 149.
9. Gugliucci A, Menini T. Circulating advanced glycation peptides in streptozotocin-induced diabetic rats: evidence for preferential modification of IgG light chains. Life Sci. 1998; 62: 2141.
10. Zilin S, Naifeng L, Bicheng L, Jiping W. The determination of AGE-peptides by flow injection assay, a practical marker of diabetic nephropathy. Clin. Chim. Acta 2001; 313: 69.
11. Sharp PS, Rainbow S, Mukherjee S. Serum levels of low molecular weight advanced glycation end products in diabetic subjects. Diabet. Med. 2003; 20: 575.
12. Deuther-Conrad W, Franke S, Sommer M, Henle T, Stein G. Differences in the modulating potential of advanced glycation end product (AGE) peptides versus AGE proteins. Kidney Int. 2001; 59: S63.
13. Lapolla A, Fedele D, Martano L, Arico NC, Garbeglio M, Traldi P, Seraglia R, Favretto D. Advanced glycation end products: a highly complex set of biologically relevant compounds detected by mass spectrometry. J. Mass Spectrom. 2001; 36: 370.
14. Lapolla A, Fedele D, Senesi A, Aricò NC, Reitano R, Seraglia R, Astner H, Traldi P. Advanced glycation end products/peptides: a preliminary investigation by LC and LC/MS. Farmaco 2002; 57: 845.
15. Marotta E, Lapolla A, Fedele D, Senesi A, Reitano R, Witt M, Seraglia R, Traldi P. Accurate mass measurements by Fourier transform mass spectrometry in the study of advanced glycation end products/peptides. J. Mass Spectrom. 2003; 38: 196.
16. Lapolla A, Fedele D, Reitano R, Aricò NC, Seraglia R, Traldi P, Marotta E, Tonani R. Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides. J. Am. Soc Mass Spectrom. 2004; 15: 496.
17. Lapolla A, Fedele D, Deraglia R, Catinella S, Baldo L, Aronica R, Traldi P. A new effective method for the evaluation of glycated intact plasma proteins in diabetic subjects. Diabetologia 1995; 38: 1076.
18. Shapiro R, McManns MJ, Zalut C, Bunn FA. Sites of non-enzymatic glycosylation of human haemoglobin. J. Biol. Chem. 1980; 235: 3120.